2023 PKD Summit - Progress in the Care of Patients with PKD - Dr. Matt Lanktree

Sdílet
Vložit
  • čas přidán 13. 12. 2023
  • Dr. Matt Lanktree discusses how genetics beyond PKD1 and PKD2 impact ADPKD, offers suggestions for how to slow cyst growth, and shares what he sees coming next in the treatment of PKD.
    Dr. Lanktree is a clinician-scientist, assistant professor, and medical director of the McMaster Kidney Genetics Clinic, caring for patients with chronic and end-stage kidney disease at St. Joseph's Healthcare Hamilton and McMaster University. Dr. Lanktree has published extensively on genetics and kidney disease, including polycystic kidney disease, and has received peer review funding from the Canadian Institutes of Health Research, the Canadian and American Societies of Nephrology, and was recently awarded the Canadian Society of Nephrology New Investigator Award. Matt has set his goal to use genetics to improve the care of patients with kidney disease.
    Learn more about the PKD Foundation of Canada on our website: www.endpkd.ca/
    Our Facebook account: / endpkd
    Our Instagram: / endpkd.ca
    Our X / Twitter account: / endpkd

Komentáře •